Pro-inflammatory complement activation by the Aβ peptide of Alzheimer’s disease is biologically significant and can be blocked by vaccinia virus complement control protein
- 1 November 1998
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 19 (6) , 619-627
- https://doi.org/10.1016/s0197-4580(98)00100-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinPublished by Elsevier ,2004
- Complement activation by cross-linked truncated and chimeric full-length β-amyloidNeuroReport, 1997
- Aggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β PeptideJournal of Neurochemistry, 1997
- Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger ReceptorNeuron, 1996
- β-Amyloid converts an acute phase injury response to chronic injury responsesNeurobiology of Aging, 1996
- Multivalent Binding of Complement Protein C1q to the Amyloid β-Peptide (Aβ) Promotes the Nucleation Phase of Aβ AggregationBiochemical and Biophysical Research Communications, 1995
- Activation of microglial cells by β-amyloid protein and interferon-γNature, 1995
- Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteinsNature, 1988
- The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein geneNature, 1987